Literature DB >> 11050015

Molecular evidence of organ-related transmission of Kaposi sarcoma-associated herpesvirus or human herpesvirus-8 in transplant patients.

M Luppi1, P Barozzi, G Santagostino, R Trovato, T F Schulz, R Marasca, D Bottalico, L Bignardi, G Torelli.   

Abstract

In transplant patients, Kaposi sarcoma (KS)-associated herpesvirus or human herpesvirus-8 (HHV-8) infection is associated with the development of KS, primary effusion lymphoma and Castleman disease. Whether HHV-8 is either reactivated in the recipient or transmitted by the donor has been investigated so far only by serologic studies. Thus, we addressed the issue of HHV-8 transmission in the transplantation setting by molecular methods. We exploited the high level variability of the orf-K1 gene and the polymorphism of the orf-73 gene of the HHV-8 genome to assess the genetic relatedness of the HHV-8 strains identified in the posttransplant KS lesions that developed, simultaneously, 20 months after transplantation, in 2 recipients of twin kidneys from the same cadaver donor. The 100% identity of nucleotide sequence of the most variable viral region and the presence of the same, single orf-73 type in both patients provides strong molecular evidence of organ-related transmission of HHV-8 in the setting of transplantation.

Entities:  

Mesh:

Year:  2000        PMID: 11050015

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  16 in total

1.  Seroprevalence of antibodies against human herpesvirus 8 in a population of renal transplant recipients at Hôtel-Dieu de Québec Hospital.

Authors:  S Delorme; I Houde; L Deschênes
Journal:  J Clin Microbiol       Date:  2003-11       Impact factor: 5.948

Review 2.  Herpesvirus infections in organ transplant recipients.

Authors:  Frank J Jenkins; David T Rowe; Charles R Rinaldo
Journal:  Clin Diagn Lab Immunol       Date:  2003-01

Review 3.  HIV/AIDS: epidemiology, pathophysiology, and treatment of Kaposi sarcoma-associated herpesvirus disease: Kaposi sarcoma, primary effusion lymphoma, and multicentric Castleman disease.

Authors:  Ryan J Sullivan; Liron Pantanowitz; Corey Casper; Justin Stebbing; Bruce J Dezube
Journal:  Clin Infect Dis       Date:  2008-11-01       Impact factor: 9.079

4.  Signaling cascades triggered by bacterial metabolic end products during reactivation of Kaposi's sarcoma-associated herpesvirus.

Authors:  T L Morris; R R Arnold; J Webster-Cyriaque
Journal:  J Virol       Date:  2007-03-21       Impact factor: 5.103

5.  Use of a multiantigen detection algorithm for diagnosis of Kaposi's sarcoma-associated herpesvirus infection.

Authors:  A Scott Laney; Jonathan S Peters; Susan M Manzi; Lawrence A Kingsley; Yuan Chang; Patrick S Moore
Journal:  J Clin Microbiol       Date:  2006-10       Impact factor: 5.948

Review 6.  Diagnosis and Treatment of Kaposi Sarcoma.

Authors:  Johann W Schneider; Dirk P Dittmer
Journal:  Am J Clin Dermatol       Date:  2017-08       Impact factor: 7.403

7.  Do fewer cases of Kaposi's sarcoma in HIV-infected patients reflect a decrease in HHV8 seroprevalence?

Authors:  Claudia Reinheimer; Regina Allwinn; Martin Stürmer
Journal:  Med Microbiol Immunol       Date:  2011-02-19       Impact factor: 3.402

8.  Charting latency transcripts in Kaposi's sarcoma-associated herpesvirus by whole-genome real-time quantitative PCR.

Authors:  Farnaz D Fakhari; Dirk P Dittmer
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

9.  Risk of occupational human herpesvirus 8 infection for health care workers.

Authors:  Barbara C Gärtner; Alexandra Kloss; Harald Kaul; Urban Sester; Klaus Roemer; Hans Pees; Hans Köhler; Nikolaus Mueller-Lantzsch
Journal:  J Clin Microbiol       Date:  2003-05       Impact factor: 5.948

10.  Update on HHV-8-Associated Malignancies.

Authors:  Meena Sunil; Erin Reid; Mary Jo Lechowicz
Journal:  Curr Infect Dis Rep       Date:  2010-03-26       Impact factor: 3.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.